Multikinase inhibitors

TEVA 8229 TEVA 8229 Pill - yellow capsule-shape, 16mm

Pill with imprint TEVA 8229 TEVA 8229 is Yellow, Capsule-shape and has been identified as Sunitinib Malate 37.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunitinib (Sunitinib [ soo-nit-in-ib ])-TEVA 8229 TEVA 8229-37.5 mg-Yellow-Capsule-shape

Sunitinib
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: TEVA 8229 TEVA 8229
Strength: 37.5 mg
Color: Yellow
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00093-8229
Inactive Ingredients: Croscarmellose sodium, Magnesium stearate, Mannitol, Povidone k30, Gelatin, Titanium dioxide, Ferric oxide yellow, Ferrosoferric oxide, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, FD&C Red No. 40, Shellac, Propylene glycol,
Latest News
Related Drugs